$5.06 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 129 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 87.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VTRS | New | VIATRIS INC | $294,668,000 | – | 15,724,000 | +100.0% | 5.82% | – |
| New | INVITAE CORPnote 2.000% 9/0 | $263,849,000 | – | 163,385,000 | +100.0% | 5.22% | – | |
| NEVRO CORPnote 1.750% 6/0 | $208,538,000 | +20.6% | 115,776,000 | 0.0% | 4.12% | -2.1% | ||
| New | NUVASIVE INCnote 2.250% 3/1 | $201,278,000 | – | 200,000,000 | +100.0% | 3.98% | – | |
| GRAY | GRAYBUG VISION INC | $153,275,000 | +128.3% | 5,281,713 | 0.0% | 3.03% | +85.3% | |
| CNC | Buy | CENTENE CORP DEL | $145,873,000 | +36.8% | 2,430,000 | +32.9% | 2.88% | +11.1% |
| New | AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $137,072,000 | – | 149,600,000 | +100.0% | 2.71% | – | |
| AFIB | ACUTUS MED INC | $125,087,000 | -3.3% | 4,341,799 | 0.0% | 2.47% | -21.5% | |
| LRMR | LARIMAR THERAPEUTICS INC | $110,145,000 | +41.1% | 5,144,539 | 0.0% | 2.18% | +14.6% | |
| BIIB | New | BIOGEN INC | $109,697,000 | – | 448,000 | +100.0% | 2.17% | – |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $104,644,000 | +77.9% | 1,442,970 | +16.9% | 2.07% | +44.3% |
| New | APELLIS PHARMACEUTICALS INCnote 3.500% 9/1 | $92,483,000 | – | 54,825,000 | +100.0% | 1.83% | – | |
| ONCR | New | ONCORUS INC | $92,107,000 | – | 2,848,977 | +100.0% | 1.82% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $90,502,000 | – | 579,248 | +100.0% | 1.79% | – |
| NKTX | Sell | NKARTA INC | $87,280,000 | +20.0% | 1,419,872 | -41.3% | 1.72% | -2.5% |
| RYTM | Buy | RHYTHM PHARMACEUTICALS INC | $80,901,000 | +96.8% | 2,721,203 | +43.4% | 1.60% | +59.7% |
| New | INSULET CORPnote 0.375% 9/0 | $76,424,000 | – | 57,581,000 | +100.0% | 1.51% | – | |
| New | INSMED INCnote 1.750% 1/1 | $69,219,000 | – | 61,000,000 | +100.0% | 1.37% | – | |
| AHCO | Buy | ADAPTHEALTH CORP | $67,846,000 | +81.8% | 1,806,332 | +5.6% | 1.34% | +47.7% |
| PCRX | Sell | PACIRA BIOSCIENCES INC | $62,811,000 | -12.8% | 1,049,647 | -12.4% | 1.24% | -29.2% |
| MIRM | MIRUM PHARMACEUTICALS INC | $60,218,000 | -9.4% | 3,448,912 | 0.0% | 1.19% | -26.5% | |
| DFPH | New | DFP HEALTHCARE ACQUISITNS CO | $58,968,000 | – | 5,460,000 | +100.0% | 1.16% | – |
| OSH | OAK STR HEALTH INC | $58,167,000 | +14.4% | 951,063 | 0.0% | 1.15% | -7.1% | |
| DFPHU | Sell | DFP HEALTHCARE ACQUISITNS COunit 03/31/2025 | $56,051,000 | -51.0% | 5,000,000 | -52.2% | 1.11% | -60.2% |
| RVMD | Sell | REVOLUTION MEDICINES INC | $55,283,000 | -11.6% | 1,396,383 | -22.3% | 1.09% | -28.2% |
| XLRN | ACCELERON PHARMA INC | $53,942,000 | +13.7% | 421,619 | 0.0% | 1.07% | -7.7% | |
| DFHT | New | DEERFIELD HEALTHCARE TECH AC | $53,333,000 | – | 3,418,750 | +100.0% | 1.05% | – |
| FATE | New | FATE THERAPEUTICS INC | $51,291,000 | – | 564,067 | +100.0% | 1.01% | – |
| CYTK | New | CYTOKINETICS INC | $51,140,000 | – | 2,461,000 | +100.0% | 1.01% | – |
| DFHTU | DEERFIELD HEALTHCARE TECH ACunit 07/16/2025 | $50,400,000 | +41.1% | 3,360,000 | 0.0% | 1.00% | +14.5% | |
| BKD | Sell | BROOKDALE SR LIVING INC | $48,834,000 | +8.5% | 11,023,465 | -37.8% | 0.96% | -12.0% |
| New | INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $45,738,000 | – | 57,791,000 | +100.0% | 0.90% | – | |
| BPMC | New | BLUEPRINT MEDICINES CORP | $45,464,000 | – | 405,386 | +100.0% | 0.90% | – |
| New | CLOVIS ONCOLOGY INCnote 2.500% 9/1 | $45,236,000 | – | 49,064,000 | +100.0% | 0.89% | – | |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS | $43,477,000 | +184.0% | 5,835,810 | +30.9% | 0.86% | +130.3% |
| CNST | Buy | CONSTELLATION PHARMCETICLS I | $42,018,000 | +106.3% | 1,458,957 | +45.1% | 0.83% | +67.3% |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $40,627,000 | +42.5% | 3,959,741 | +40.1% | 0.80% | +15.7% |
| VIVO | Buy | MERIDIAN BIOSCIENCE INC | $40,389,000 | +57.7% | 2,161,000 | +43.3% | 0.80% | +27.9% |
| BDSI | Buy | BIODELIVERY SCIENCES INTL IN | $40,026,000 | +40.5% | 9,530,000 | +24.8% | 0.79% | +14.1% |
| AXNX | Buy | AXONICS MODULATION TECHNOLOG | $39,936,000 | +0.8% | 800,000 | +3.1% | 0.79% | -18.2% |
| ISEE | IVERIC BIO INC | $39,853,000 | +22.5% | 5,767,409 | 0.0% | 0.79% | -0.5% | |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $39,558,000 | -9.4% | 320,000 | -28.6% | 0.78% | -26.4% |
| QDEL | Buy | QUIDEL CORP | $39,523,000 | +38.0% | 220,000 | +68.6% | 0.78% | +12.1% |
| EDIT | Sell | EDITAS MEDICINE INC | $37,770,000 | +36.1% | 538,721 | -45.5% | 0.75% | +10.4% |
| OLMA | New | OLEMA PHARMACEUTICALS INC | $33,473,000 | – | 696,191 | +100.0% | 0.66% | – |
| LUMO | LUMOS PHARMA INC | $33,435,000 | +158.4% | 936,291 | 0.0% | 0.66% | +109.8% | |
| LUNG | New | PULMONX CORP | $31,992,000 | – | 463,511 | +100.0% | 0.63% | – |
| NUVA | New | NUVASIVE INC | $31,826,000 | – | 565,000 | +100.0% | 0.63% | – |
| XERIS PHARMACEUTICALS INCnote 5.000% 7/1 | $31,658,000 | -12.3% | 18,000,000 | 0.0% | 0.63% | -28.8% | ||
| New | NOVAVAX INCnote 3.750% 2/0 | $31,326,000 | – | 25,000,000 | +100.0% | 0.62% | – | |
| SHC | New | SOTERA HEALTH CO | $30,486,000 | – | 1,111,000 | +100.0% | 0.60% | – |
| DCPH | DECIPHERA PHARMACEUTICALS IN | $30,166,000 | +11.2% | 528,585 | 0.0% | 0.60% | -9.7% | |
| ORTX | ORCHARD THERAPEUTICS PLCads | $30,021,000 | +5.1% | 6,949,416 | 0.0% | 0.59% | -14.7% | |
| KOD | Sell | KODIAK SCIENCES INC | $29,735,000 | +1.0% | 202,406 | -59.3% | 0.59% | -18.0% |
| OMI | Sell | OWENS & MINOR INC NEW | $29,647,000 | -20.1% | 1,096,000 | -25.8% | 0.59% | -35.1% |
| ANNX | Sell | ANNEXON INC | $29,231,000 | -40.2% | 1,167,826 | -27.8% | 0.58% | -51.5% |
| ATEC | New | ALPHATEC HLDGS INC | $29,040,000 | – | 2,000,000 | +100.0% | 0.57% | – |
| STTK | New | SHATTUCK LABS INC | $28,826,000 | – | 550,000 | +100.0% | 0.57% | – |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INC | $27,820,000 | +20.6% | 1,379,971 | +16.9% | 0.55% | -2.1% |
| ACCD | Buy | ACCOLADE INC | $27,753,000 | +14.4% | 638,001 | +2.2% | 0.55% | -7.1% |
| GBIO | GENERATION BIO CO | $27,250,000 | -8.3% | 961,215 | 0.0% | 0.54% | -25.4% | |
| MOH | Sell | MOLINA HEALTHCARE INC | $26,585,000 | -5.1% | 125,000 | -18.3% | 0.52% | -23.0% |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $26,064,000 | +5.2% | 2,404,439 | 0.0% | 0.52% | -14.6% | |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $25,720,000 | +6.0% | 802,511 | 0.0% | 0.51% | -14.0% | |
| INZY | INOZYME PHARMA INC | $23,742,000 | -21.5% | 1,150,299 | 0.0% | 0.47% | -36.3% | |
| New | PACIRA BIOSCIENCES INCnote 2.375% 4/0 | $22,719,000 | – | 20,000,000 | +100.0% | 0.45% | – | |
| OSUR | Sell | ORASURE TECHNOLOGIES INC | $22,488,000 | -14.5% | 2,124,515 | -1.7% | 0.44% | -30.6% |
| NEVRO CORPnote 2.750% 4/0 | $21,915,000 | +16.7% | 12,000,000 | 0.0% | 0.43% | -5.3% | ||
| MAACU | New | MONTES ARCHIMEDES ACQUISITIOunit 09/30/2025 | $21,000,000 | – | 2,000,000 | +100.0% | 0.42% | – |
| CERT | New | CERTARA INC | $20,232,000 | – | 600,000 | +100.0% | 0.40% | – |
| AMWL | AMERICAN WELL CORPcl a | $20,039,000 | -14.5% | 791,115 | 0.0% | 0.40% | -30.6% | |
| PRAX | New | PRAXIS PRECISION MEDICINES I | $19,257,000 | – | 350,000 | +100.0% | 0.38% | – |
| TARA | PROTARA THERAPEUTICS INC | $18,948,000 | +43.9% | 782,670 | 0.0% | 0.37% | +16.5% | |
| PTC THERAPEUTICS INCnote 3.000% 8/1 | $18,577,000 | +12.8% | 14,527,000 | 0.0% | 0.37% | -8.5% | ||
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $18,321,000 | +149.3% | 1,049,035 | +67.0% | 0.36% | +102.2% |
| MDVL | New | MEDAVAIL HOLDINGS INC | $17,195,000 | – | 1,142,552 | +100.0% | 0.34% | – |
| ARDX | ARDELYX INC | $16,573,000 | +23.2% | 2,561,554 | 0.0% | 0.33% | +0.3% | |
| ALGS | New | ALIGOS THERAPEUTICS INC | $16,590,000 | – | 600,000 | +100.0% | 0.33% | – |
| VAPO | New | VAPOTHERM INC | $16,237,000 | – | 604,520 | +100.0% | 0.32% | – |
| ALEC | Sell | ALECTOR INC | $15,965,000 | +3.7% | 1,055,192 | -27.8% | 0.32% | -15.7% |
| ITMR | Buy | ITAMAR MED LTDsponsored ads | $15,765,000 | +54.6% | 793,803 | +59.0% | 0.31% | +25.8% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $15,699,000 | +169.9% | 1,162,033 | +135.1% | 0.31% | +118.3% |
| SEM | SELECT MED HLDGS CORP | $15,628,000 | +32.9% | 565,000 | 0.0% | 0.31% | +8.0% | |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $14,916,000 | – | 575,000 | +100.0% | 0.30% | – |
| BSX | New | BOSTON SCIENTIFIC CORP | $14,632,000 | – | 407,000 | +100.0% | 0.29% | – |
| ZBH | New | ZIMMER BIOMET HOLDINGS INC | $14,639,000 | – | 95,000 | +100.0% | 0.29% | – |
| CDAK | New | CODIAK BIOSCIENCES INC | $14,535,000 | – | 450,000 | +100.0% | 0.29% | – |
| SYK | New | STRYKER CORPORATION | $14,457,000 | – | 59,000 | +100.0% | 0.29% | – |
| PROF | PROFOUND MED CORP | $14,289,000 | +16.5% | 695,000 | 0.0% | 0.28% | -5.7% | |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $14,293,000 | – | 163,000 | +100.0% | 0.28% | – |
| SRRK | New | SCHOLAR ROCK HLDG CORP | $14,019,000 | – | 288,876 | +100.0% | 0.28% | – |
| KNTE | New | KINNATE BIOPHARMA INC | $13,724,000 | – | 345,000 | +100.0% | 0.27% | – |
| IMRA | Buy | IMARA INC | $12,742,000 | +21.0% | 577,868 | +11.6% | 0.25% | -1.6% |
| DYN | Buy | DYNE THERAPEUTICS INC | $11,970,000 | +44.2% | 570,000 | +38.6% | 0.24% | +17.3% |
| RNA | Sell | AVIDITY BIOSCIENCES INC | $11,585,000 | -13.2% | 453,973 | -4.3% | 0.23% | -29.5% |
| PMVP | Buy | PMV PHARMACEUTICALS INC | $11,514,000 | +548.7% | 187,192 | +274.4% | 0.23% | +430.2% |
| COGT | New | COGENT BIOSCIENCES INC | $11,230,000 | – | 1,000,000 | +100.0% | 0.22% | – |
| AVRO | New | AVROBIO INC | $11,152,000 | – | 800,000 | +100.0% | 0.22% | – |
| EUCRU | New | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $10,660,000 | – | 1,000,000 | +100.0% | 0.21% | – |
| SRSAU | New | SARISSA CAPITAL ACQUISITN COunit 10/23/2027 | $10,650,000 | – | 1,000,000 | +100.0% | 0.21% | – |
| MTACU | New | MEDTECH ACQUISITION CORPunit 12/18/2025 | $10,500,000 | – | 1,000,000 | +100.0% | 0.21% | – |
| CAPAU | HIGHCAPE CAP ACQUISITION CORunit 09/30/2027 | $10,320,000 | +2.0% | 1,000,000 | 0.0% | 0.20% | -17.1% | |
| SNRHU | New | SENIOR CONNECT ACQUISITN CORunit 12/09/2023 | $10,290,000 | – | 1,000,000 | +100.0% | 0.20% | – |
| TPTX | New | TURNING POINT THERAPEUTICS I | $10,217,000 | – | 83,846 | +100.0% | 0.20% | – |
| STIM | Sell | NEURONETICS INC | $10,210,000 | +33.4% | 919,000 | -41.7% | 0.20% | +8.6% |
| OM | Buy | OUTSET MED INC | $9,947,000 | +59.2% | 175,000 | +40.0% | 0.20% | +29.6% |
| BCAB | New | BIOATLA INC | $9,537,000 | – | 280,422 | +100.0% | 0.19% | – |
| DCTH | New | DELCATH SYS INC | $8,960,000 | – | 500,000 | +100.0% | 0.18% | – |
| TMPMU | New | TURMERIC ACQUISITION CORPunit 10/08/2025 | $7,703,000 | – | 750,000 | +100.0% | 0.15% | – |
| SIEN | Sell | SIENTRA INC | $7,461,000 | -5.4% | 1,918,118 | -17.3% | 0.15% | -23.4% |
| SILK | New | SILK RD MED INC | $7,117,000 | – | 113,000 | +100.0% | 0.14% | – |
| TSHA | TAYSHA GENE THERAPIES INC | $6,635,000 | +18.5% | 250,000 | 0.0% | 0.13% | -3.7% | |
| PANAU | PANACEA ACQUISITION CORPunit 99/99/9999 | $6,381,000 | +6.4% | 500,000 | 0.0% | 0.13% | -13.7% | |
| CERE | New | CEREVEL THERAPEUTICS HLDNG I | $6,384,000 | – | 385,043 | +100.0% | 0.13% | – |
| ARVN | Sell | ARVINAS INC | $6,370,000 | -56.1% | 75,000 | -87.8% | 0.13% | -64.3% |
| FDMT | New | 4D MOLECULAR THERAPEUTICS IN | $6,218,000 | – | 150,000 | +100.0% | 0.12% | – |
| XENT | Sell | INTERSECT ENT INC | $5,850,000 | -77.2% | 255,456 | -83.8% | 0.12% | -81.4% |
| CABA | CABALETTA BIO INC | $5,794,000 | +15.1% | 464,252 | 0.0% | 0.12% | -6.5% | |
| New | BENEFITFOCUS INCnote 1.250%12/1 | $5,713,000 | – | 6,500,000 | +100.0% | 0.11% | – | |
| EAR | New | EARGO INC | $5,603,000 | – | 125,000 | +100.0% | 0.11% | – |
| CHFWU | New | CONSONANCE HFW ACQUISITION Cunit 99/99/9999 | $5,235,000 | – | 500,000 | +100.0% | 0.10% | – |
| LGVWWS | New | LONGVIEW ACQUISITION CORP*w exp 05/27/202 | $4,833,000 | – | 733,333 | +100.0% | 0.10% | – |
| MASS | New | 908 DEVICES INC | $4,271,000 | – | 75,000 | +100.0% | 0.08% | – |
| MTCR | Sell | METACRINE INC | $2,181,000 | -77.0% | 277,469 | -70.1% | 0.04% | -81.4% |
| VCEL | Sell | VERICEL CORP | $2,006,000 | -92.7% | 64,946 | -95.6% | 0.04% | -94.0% |
| FUSN | Sell | FUSION PHARMACEUTICALS INC | $1,908,000 | -83.7% | 162,378 | -83.3% | 0.04% | -86.6% |
| CEREW | New | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $942,000 | – | 166,666 | +100.0% | 0.02% | – |
| NEOS | NEOS THERAPEUTICS INC | $201,000 | +18.2% | 320,993 | 0.0% | 0.00% | 0.0% | |
| WINT | WINDTREE THERAPEUTICS INC | $103,000 | -7.2% | 20,148 | 0.0% | 0.00% | -33.3% | |
| Exit | ALIMERA SCIENCES INC | $0 | – | -68,413 | -100.0% | -0.01% | – | |
| CERS | Exit | CERUS CORP | $0 | – | -85,143 | -100.0% | -0.01% | – |
| MNKKQ | Exit | MALLINCKRODT PUB LTD CO | $0 | – | -1,970,687 | -100.0% | -0.05% | – |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -348,441 | -100.0% | -0.05% | – |
| GNMK | Exit | GENMARK DIAGNOSTICS INC | $0 | – | -175,806 | -100.0% | -0.06% | – |
| ARYBU | Exit | ARYA SCIENCES ACQUISTION COunit 06/09/2027 | $0 | – | -500,000 | -100.0% | -0.13% | – |
| ATHA | Exit | ATHIRA PHARMA INC | $0 | – | -450,000 | -100.0% | -0.20% | – |
| GOCO | Exit | GOHEALTH INC | $0 | – | -700,000 | -100.0% | -0.22% | – |
| ADCT | Exit | ADC THERAPEUTICS SA | $0 | – | -300,000 | -100.0% | -0.24% | – |
| ATNX | Exit | ATHENEX INC | $0 | – | -1,150,000 | -100.0% | -0.34% | – |
| NTRA | Exit | NATERA INC | $0 | – | -208,333 | -100.0% | -0.37% | – |
| SLQT | Exit | SELECTQUOTE INC | $0 | – | -750,000 | -100.0% | -0.37% | – |
| NNOX | Exit | NANO X IMAGING LTD | $0 | – | -762,000 | -100.0% | -0.44% | – |
| LGVWU | Exit | LONGVIEW ACQUISITION CORPunit 99/99/9999 | $0 | – | -2,200,000 | -100.0% | -0.54% | – |
| Exit | PACIRA BIOSCIENCESnote 2.375% 4/0 | $0 | – | -20,000,000 | -100.0% | -0.56% | – | |
| TCRR | Exit | TCR2 THERAPEUTICS INC | $0 | – | -1,200,000 | -100.0% | -0.59% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -388,000 | -100.0% | -0.63% | – |
| EHTH | Exit | EHEALTH INC | $0 | – | -333,411 | -100.0% | -0.64% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -668,067 | -100.0% | -0.65% | – |
| GKOS | Exit | GLAUKOS CORP | $0 | – | -695,523 | -100.0% | -0.84% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -405,386 | -100.0% | -0.92% | – |
| Exit | CLOVIS ONCOLOGY INCnote 2.500% 9/1 | $0 | – | -49,064,000 | -100.0% | -1.07% | – | |
| Exit | INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $0 | – | -57,791,000 | -100.0% | -1.13% | – | |
| Exit | INSMED INCnote 1.750% 1/1 | $0 | – | -61,000,000 | -100.0% | -1.61% | – | |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -579,248 | -100.0% | -1.61% | – |
| Exit | APELLIS PHARMACEUTICALS INCnote 3.500% 9/1 | $0 | – | -64,825,000 | -100.0% | -1.70% | – | |
| Exit | DEXCOM INCnote 0.750%12/0 | $0 | – | -34,000,000 | -100.0% | -2.09% | – | |
| Exit | NUVASIVE INCnote 2.250% 3/1 | $0 | – | -85,000,000 | -100.0% | -2.13% | – | |
| MYOK | Exit | MYOKARDIA INC | $0 | – | -704,000 | -100.0% | -2.34% | – |
| Exit | AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $0 | – | -149,600,000 | -100.0% | -2.92% | – | |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -1,832,767 | -100.0% | -3.47% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -2,304,900 | -100.0% | -4.77% | – |
| MYL | Exit | MYLAN NV | $0 | – | -13,274,000 | -100.0% | -4.79% | – |
| Exit | INVITAE CORPnote 2.000% 9/0 | $0 | – | -163,385,000 | -100.0% | -6.52% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.